mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal
Supporting Files
Public Domain
-
Aug 2017
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes.
-
Subjects:
-
Source:Emerg Infect Dis. 23(8):1419-1421.
-
Pubmed ID:28726622
-
Pubmed Central ID:PMC5547783
-
Document Type:
-
Place as Subject:
-
Location:
-
Volume:23
-
Issue:8
-
Collection(s):
-
Main Document Checksum:urn:sha256:85ba9fc5bb6018c10969dafd9afaee62aebb16eaf0d1b7610db2d3ff46ec4d5f
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases